Commodore Capital LP 13D/13G Filings for Cardiff Oncology, Inc. (CRDF)

Commodore Capital LP 13D and 13G filings for Cardiff Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-12-17
4:06 pm
Purchase
2024-12-10 13G Cardiff Oncology, Inc.
CRDF
Commodore Capital LP 5,384,616
8.100%
5,384,616increase
(New Position)
Filing